Wash U, Rare Genomics Institute Launch 99 Exome Challenge, Clinical Exome Sequencing Service | GenomeWeb

In conjunction with Rare Disease Day, Washington University School of Medicine's Genomics and Pathology Services and the Rare Genomics Institute said today that they will award grants for the sequencing of 99 exomes to rare disease advocacy groups.

The goal of the Rare 99X Clinical Exome Challenge is to use exome sequencing to better understand the molecular causes of rare disease. Interested applicants should submit letters of interest by April 2, with more in-depth grant proposals from selected applicants by June 1, and final award decisions made by July 2.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.